Search

everythinglearnresearchcommunity

for

Search:↓

Using Janus kinase inhibitors (JAKi) in COVID-19 treatment requires careful consideration due to their immunosuppressive effects.

No significant link between male pattern baldness and severe Covid-19, but some shared biological pathways exist.

Proxalutamide significantly lowered hospital admissions for male COVID-19 patients compared to a placebo.

Some drugs may help treat both COVID-19 and radiation injury.

Some nutraceuticals may help in COVID-19 prevention and treatment, but more research is needed.

Long COVID-19 patients with skin pain might have a nerve condition that responds to a medication called gabapentin.

Using mesenchymal stem cells or their exosomes is safe for COVID-19 patients and helps improve lung healing and oxygen levels.

Many hospitalized children with COVID-19 had skin, mouth, or nail changes, with skin rashes being common.

Extracellular water levels don't indicate COVID-19 pneumonia severity.

Patients treated in Respiratory Intensive Care Units for COVID-19 are more likely to get mood disorders than those in other care settings.

COVID-19 can cause skin symptoms that might help spot the virus early, and treatments for it can also affect the skin.

Collider bias can mislead our understanding of COVID-19 risk and severity.

Fatigue is the most common symptom in both ongoing symptomatic COVID-19 and post-COVID-19 syndrome.

COVID-19 severely affects older adults with chronic heart, lung, or metabolic diseases.

COVID-19 can cause long-term health issues in many body systems, and vaccination is important to prevent these effects.

70.7% of patients had long-COVID symptoms like fatigue, cough, and brain fog three months after recovery.

Teledermatology became a valuable and convenient tool for skin care during the COVID-19 pandemic.

COVID-19 patients often experience hair loss and scalp pain, which may be related to the severity of their infection and treatment drugs.

Older males had higher death rates, and Latin Americans were more often in the ICU during the COVID-19 outbreak in a Spanish hospital.

COVID-19 vaccines can trigger autoimmune flares but are still beneficial for patients with autoimmune conditions.

African Americans faced worse COVID-19 outcomes due to a mix of social, environmental, and biological factors.

A patient developed a severe skin reaction and died after taking hydroxychloroquine for COVID-19.

Old age, male sex, smoking, and obesity may affect COVID-19 severity, but more research is needed.

Long COVID symptoms are linked to immune issues, poor blood flow, and lung problems.

Proxalutamide improved recovery, lowered death rates, and reduced hospital stay for COVID-19 patients.

COVID-19 can cause various skin issues, like rashes and lesions, which are more common in younger patients and can be linked to more severe complications.

Public interest in skin issues changed during COVID-19, with more focus on dry skin, hair problems, and hand eczema.

iPSCs are promising for studying and treating COVID-19.